TG

Tina Gullotta

Tina Gullotta


Vice President Finance | San Francisco, California, United States

Professional Overview


Tina Gullotta is an accomplished finance executive with extensive experience in the biotechnology and pharmaceutical industries. As the Vice President of Finance at Frontier Medicines, she leverages her strategic financial expertise to support the company's growth and drive sustainable value creation.

Experience Summary



Current Role


Tina currently serves as the Vice President of Finance at Frontier Medicines, a position she has held since November 2021. In this role, she is responsible for overseeing the company's financial operations, including budgeting, forecasting, and financial reporting. Tina plays a crucial part in aligning Frontier Medicines' financial strategies with its overall business objectives, ensuring the company remains financially robust and well-positioned for success.

Career Progression


Prior to her current role, Tina held various finance leadership positions within the biotechnology industry. She served as the Vice President of Finance at Sunesis Pharmaceuticals, Inc., where she was instrumental in managing the company's financial activities and supporting its transition. Before that, Tina was the Corporate Controller at Sunesis Pharmaceuticals, Inc., and the Head of Investor Relations & Treasurer at Atara Biotherapeutics, Inc. Her early career included roles as a Finance Consultant, Corporate Controller, and Senior Associate at PricewaterhouseCoopers.

Academic Background


Tina holds a Bachelor's degree in Accounting from a prestigious university, demonstrating her strong academic foundation in finance and accounting.

Areas of Expertise


  • Financial planning and analysis

  • Budgeting and forecasting

  • Financial reporting and compliance

  • Investor relations and treasury management

  • Strategic financial decision-making

  • Operational and process optimization


Professional Impact


Throughout her career, Tina has demonstrated a proven track record of driving financial excellence and contributing to the success of the organizations she has served. Her financial leadership and strategic insights have been instrumental in supporting the growth and transformation of several biotechnology companies. Tina is recognized for her ability to navigate complex financial landscapes, identify opportunities for improvement, and implement solutions that enhance overall financial performance and shareholder value.

Conclusion


With her extensive experience, deep industry expertise, and strong financial acumen, Tina Gullotta is poised to continue making a significant impact as the Vice President of Finance at Frontier Medicines. Her unwavering commitment to financial excellence and her collaborative approach to problem-solving make her a valuable asset to the organization and the biotechnology industry as a whole.